购物车
- 全部删除
- 您的购物车当前为空
PSMA-ALB-56是通过结合谷氨酸脲基 psma 结合实体、DOTA 螯合剂和基于4-(对碘苯基)-片段或 p(tolyl)-片段的白蛋白结合剂而设计的一种 PSMA-targeting 放射性配体,具有抗肿瘤活性。
PSMA-ALB-56是通过结合谷氨酸脲基 psma 结合实体、DOTA 螯合剂和基于4-(对碘苯基)-片段或 p(tolyl)-片段的白蛋白结合剂而设计的一种 PSMA-targeting 放射性配体,具有抗肿瘤活性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 8,950 | 期货 |
产品描述 | PSMA-ALB-56 is a PSMA-targeting radioactive ligand with antitumor activity designed by binding glutamic urea PSMA binding entities, DOTA chelating agents, and albumin binators based on 4-(p-iodophenyl)- fragment or p(tolyl)- fragment. |
体内活性 | PSMA-ALB-56 accumulates much faster in tumor tissues and is more efficiently cleared from the blood and background tissues, which results in excellent tumor-to-background contrast already 4 hours after injection. PSMA-ALB-56 increases median survival in mice [1] . |
分子量 | 1330.52 |
分子式 | C66H95N11O18 |
CAS No. | 2306049-48-7 |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.